Overview

Knee Injection RCT

Status:
Terminated
Trial end date:
2019-07-16
Target enrollment:
Participant gender:
Summary
Hypothesis: Ketorolac injection is a cost-effective adjunct in the nonoperative treatment of knee osteoarthritis (OA) compared to steroids and viscosupplementation. Aims/objectives: The objective of this randomized, controlled, double-blinded, prospective study is to assess the efficacy and cost-effectiveness of knee injection with ketorolac in the nonsurgical management of symptomatic OA compared to injections with corticosteroids and viscosupplements.
Phase:
Phase 4
Details
Lead Sponsor:
UConn Health
Collaborator:
Orthopedic Research and Education Foundation
Treatments:
Epinephrine
Epinephryl borate
Hyaluronic Acid
Hylan
Ketorolac
Ketorolac Tromethamine
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate
Racepinephrine
Ropivacaine